Evidence map›Paper›PMID 24733670›Full record

ArticleTransgenic research2014

Transportability of confined field trial data for environmental risk assessment of genetically engineered plants: a conceptual framework.

Monica Garcia-Alonso, Paul Hendley, Franz Bigler, Edgar Mayeregger, Ronald Parker, Clara Rubinstein, Emilio Satorre, Fernando Solari, Morven A McLean

Abstract read
In one paragraph

Article in Transgenic research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Plant background, notFrontiers in plant science · 2026
    Article
  2. Article
  3. Review
  4. One risk assessment for genetically modified plants.Frontiers in bioengineering and biotechnology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Update of Argentina's Regulatory Policies on the Environmental Risk Assessment.Frontiers in bioengineering and biotechnology · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Monica Garcia-AlonsoEstel Consult Ltd., 5 Hillside Drive, Binfield, Berkshire, RG42 4HG, UK.
Paul Hendley
Franz Bigler
Edgar Mayeregger
Ronald Parker
Clara Rubinstein
Emilio Satorre
Fernando Solari
Morven A McLean

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is commonly held that confined field trials (CFTs) used to evaluate the potential adverse environmental impacts of a genetically engineered (GE) plant should be conducted in each country where cultivation is intended, even when relevant and potentially sufficient data are already available from studies conducted elsewhere. The acceptance of data generated in CFTs "out of country" can only be realized in practice if the agro-climatic zone where a CFT is conducted is demonstrably representative of the agro-climatic zones in those geographies to which the data will be transported. In an attempt to elaborate this idea, a multi-disciplinary Working Group of scientists collaborated to develop a conceptual framework and associated process that can be used by the regulated and regulatory communities to support transportability of CFT data for environmental risk assessment (ERA). As proposed here, application of the conceptual framework provides a scientifically defensible process for evaluating if existing CFT data from remote sites are relevant and/or sufficient for local ERAs. Additionally, it promotes a strategic approach to identifying CFT site locations so that field data will be transportable from one regulatory jurisdiction to another. Application of the framework and process should be particularly beneficial to public sector product developers and small enterprises that develop innovative GE events but cannot afford to replicate redundant CFTs, and to regulatory authorities seeking to improve the deployment of limited institutional resources.

Indexed as

Consumer Product SafetyStatistics as TopicEnvironmental ExposureHumansPlants, Genetically ModifiedRisk Assessment

Identifiers

PMID24733670
PMCPMC4204004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.